Clinical Trial Update: MOBoxy: MoblO2 to Maintain Oxygenation [NA]

View source ↗

Summary

This clinical trial update describes a study of MOBoxy (MoblO2) intended to maintain oxygenation in patients with COPD and interstitial lung disease; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Interstitial Lung Disease

Drugs mentioned

• MOBoxy

Snippet

Sponsor: National Jewish Health | Conditions: COPD, Interstitial Lung Disease | NA | Status: NOT_YET_RECRUITING